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The currentpracticeof“FineNeedleAspirationCytology
(FNAC) has established itself as an important modality in
thediagnosis andmanagement ofsuperﬁcial anddeepseated
lesions throughout the body. With this wide employment
of FNAC, the cytopathologists play a pivotal role in the
management and therapeutic decisions that are based on the
diagnosis of these limited FNAC samples. Furthermore, the
use of FNAC samples for biomarker research is advancing
rapidly and is being widely investigated and applied for the
treatment and prognostic purposes.
In this special issue, we have made an attempt to provide
a “ﬂavor” of the current practice of FNAC with an emphasis
on correlation of tissue biopsies with PET results, FNAC of
breast, liver, pulmonary, and head and neck lesions. Simi-
larly, the use of FNAC in the diagnosis of Langerhans cell
histiocytosis,neuriticleprosy,andgranulomatousinﬂamma-
tion is also discussed.
With the increasing use of image-assisted FNAC, pathol-
ogists are now an integral part in the diagnosis and manage-
ment of the deep seated lesions. In lieu of this, it has become
important for the pathologists to be aware of the limitations
ofdiﬀerentimagingtechniques.The paperonthecorrelation
oftissuebiopsieswith PETresultsdiscusses thelimitations of
an increased SUV value on PET scan.
The use of ﬁne needle aspiration cytologyhas been prov-
en to give fast, economical, and valuable diagnosis of palpa-
ble breast lumps. In this issue, the role of FNAC in the eval-
uation of breast lump in a high patient volume center is
addressed with emphasis on the importance of skill and
training for both pathologists and technicians to prevent
suboptimal sampling, thus, increasing the reliability of the
procedure. Another important but not commonly discussed
aspect of breast FNAC—the nonmalignant categories—is
also addressed, with a review of the cytomorphology of be-
nign breast lumps, some of which could be mistaken for
malignancy due to the diaphanous appearance and overlap-
ping cytologic features. The false negative and false positive
FNACisfurtherdiscussed indetailsoastoavertmisinterpre-
tation. These provide practical information for readers when
dealing with FNAC of breast lesions.
The paper on liver FNAC covers various aspects and
discusses the role of FNAC in liver lesions. There is an active
debate about the preoperative/pretransplantation diagnostic
role of FNAC of hepatocellular carcinoma (HCC) and pre-
cursor lesions, especially in the face of advances in dynamic
imaging techniques. New trends in personalized molecular
targeted therapy require better characterization and predic-
tion of HCC behavior. FNAC biopsy technique is still the
mostminimally invasiveapproachfortheprocurementoftu-
mor and peritumoral tissue for molecular studies. Thus, in
the near future, hepatic FNAC is likely to become a point of
care in the management of HCC patients, especially inoper-
able cases.
Inthecurrenteraofpersonalizedmedicine,theFNACdi-
agnosis of nonsmall cell carcinoma for a pulmonary nodule
is no longer considered an adequate diagnosis. Pathologists
are often required to further subclassify these in to adeno-
carcinoma and squamous cell carcinoma. With the increas-
ing use of image-assisted FNAC including endobronchial2 Pathology Research International
ultrasound guided FNAC (EBUS-FNA), cytologic or small
biopsy material has become the only form of tissue available
for diagnosis. The paper on FNAC of pulmonary lesions
reviewsthecurrentconceptsinthesuitabilityandaccuracyof
FNAC in lung cancers including diagnosis, classiﬁcation, use
of ancillary techniques, and prognostic marker assessment.
FNAC is a valuable technique in the workup of nodules
and masses arising within the head and neck region. It is
primarily utilized to conﬁrm or exclude the diagnosis of
malignancy involving headand neckorgansespecially lymph
nodes, thyroid, and salivary glands. It has been shown that
FNAC of salivary gland lesions is a valuable way to preoper-
atively assess lesional tissue, determine the need for surgical
intervention, and assist in planning the appropriate surgical
approach prior to resection. In this issue, the manuscript on
cytologic diagnosis of mucoepidermoid carcinoma discusses
the role of FNAC in the diagnosis of mucoepidermoid
carcinoma (MEC), the common malignant tumor aﬀecting
parotid gland. In addition, it also brings forth how the rare
and recently described oncocytic variant can pose problems
in the diagnosis of MEC.
In conclusion, this special issue includes a potpourri of
topicswhichprovidesathoughtfulglimpseintovarioustech-
niques,diagnosticability,andlimitationsofthecurrentprac-
tice of FNAC.
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